Physician profile
John William Tyson
NPI 1649265117
$5,861.67
in general payments reported to CMS, 2019-2025
13 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $595 · 2024: $4,904 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,512 · Food and Beverage: $2,026 · Travel and Lodging: $1,315 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,512.00 |
| Food and Beverage | $2,025.57 |
| Travel and Lodging | $1,315.36 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,480.35 | 2024-2025 | |
| Acumed LLC | $248.42 | 2023 | Ribloc, Biobridge |
| Davol INC. | $207.52 | 2023-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $201.35 | 2024 | Phasix Mesh |
| Depuy Synthes Sales INC. | $195.92 | 2023-2024 | Matrixrib, Na, Xcm Biologic Tissue Matrix |
| Boston Scientific Corporation | $149.84 | 2025 | Wallflex Duodenal |
| W. L. Gore & Associates, INC. | $114.84 | 2024-2025 | Gore Synecor Biomaterial |
| Medtronic, INC. | $88.25 | 2023-2024 | Progrip, Sonicision |
| Ethicon US, LLC | $80.48 | 2024 | Stratafix, Vistaseal |
| Angiodynamics, INC. | $42.01 | 2023 | Smart Port Ct |
| Smith+Nephew, INC. | $20.63 | 2024 | Renasys Touch |
| Astrazeneca Pharmaceuticals LP | $18.03 | 2024 | Andexxa |
| Conmed Corporation | $14.03 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.